Review Article
Is Gastroparesis Found More Frequently in Patients with Cystic Fibrosis? A Systematic Review
Table 1
Studies evaluating gastric emptying in cystic fibrosis.
| Author | Year | Location | Subjects | Gender | Age | DM | Pancreatic insufficiency | Intervention | Result | Male | Mean | CF | Controls | Total | CF | Controls | CF | Controls | CF | Controls | CF | Controls |
| Capsule methods |
Hedsund et al. [14] | 2012 | Denmark | 10 | 16 | 26 | 5 | 9 | 23 | 26 | 0 | 0 | 10 | 0 | No | No difference |
Gelfond et al. [15] | 2013 | Buffalo, NY | 10 | 10 | 20 | 3 | 3 | 21.7 | 22.5 | 0 | 0 | 10 | 0 | No | No difference |
| C-Octanoic breath test |
De Boeck et al. [5] | 1998 | Belgium | 11 | — | 11 | 4 | — | 10.5 | — | — | — | 11 | — | Creon and high-lipase Creon in CF. | No control group |
Symonds et al. [9] | 2003 | Australia | 10 | 12 | 22 | 5 | 7 | 10.2 | 12.5 | NA | 0 | 10 | 0 | Pancreas in CF | No difference |
Neumann et al. [16] | 2003 | Czech Republic | 20 | — | 20 | NA | — | 13.5 | — | — | — | — | — | No | No difference |
Hauser et al. [17] | 2010 | Belgium | 19 | — | 19 | 13 | — | 5 | — | — | — | — | — | No | No control group |
Pauwels et al. [18] | 2011 | Belgium | 33 | — | 33 | 18 | — | 28 | — | 0 | — | 31 | — | No | No control group |
Hauser et al. [19] | 2013 | Belgium | 22 | — | 22 | 12 | — | 9 | — | — | — | 0 | — | No | No control group |
| Scintigraphy with technetium |
Davidson et al. [20] | 1995 | Canada | 70 | — | 70 | NA | — | NA | — | — | — | — | — | No | No control group |
Carney et al. [21] | 1995 | Australia | 5 | 11 | 16 | 3 | 4 | 25 | 21 | 0 | 0 | 5 | 0 | No | CF Faster |
Collins et al. [22] | 1997 | Australia | 19 | 17 | 36 | 8 | 8 | 12.6 | 12.8 | 2 | 0 | 19 | 0 | Usual dose of PERT in CF | CF Faster |
Munck et al. [23] | 1997 | France | 7 | — | 7 | NA | — | NA | — | — | — | — | — | Erythromycin in CF | No control group |
Couturier et al. [24] | 2004 | France | 48 | 53 | 101 | NA | 42 | NA | 31.84 | NA | 0 | NA | 0 | No | CF Slower |
King et al. [25] | 2006 | Australia | 22 | — | 22 | 8 | — | NA | — | — | — | 18 | — | Usual dose of PERT in CF | No control group |
Tonelli et al. [26] | 2009 | Gainesville, FL | 5 | — | 5 | 1 | — | 25.2 | — | 2 | — | 5 | — | IV Erythromycin in CF | No control group |
Luu et al. [27] | 2011 | Canada | 17 | — | 17 | NA | — | NA | — | — | — | — | — | Measurements before and after Cisapride in CF | No control group |
Kuo et al. [28] | 2011 | Australia | 5 | 6 | 11 | 3 | 3 | 25.8 | 21.7 | 0 | 0 | 5 | 6 | Creon versus Placebo in CF | CF Faster |
Mendez et al. [29] | 2012 | Chicago, Il | 10 | 78 | 88 | 8 | 38 | 28 | 59 | NA | NA | NA | NA | No | CF Slower |
Rovner et al. [4] | 2013 | Philadelphia, PA | 16 | 12 | 28 | 9 | 6 | 16.7 | 28.6 | 0 | 0 | 16 | 0 | Creon in CF | No difference | | | | 359 | 215 | 574 | 100 (50.76%) | 120 (55.81%) | | | 4 (5.71%) | 0 (0.00%) | 140 (84.85%) | 6 (4.38%) | | |
|
|
Of available data. CF: cystic fibrosis and NA: data not available.
|